Cargando…

Raw and Purified Clay Minerals for Drug Delivery Applications

[Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekaroğlu, Gökçe Maide, İşçi, Sevim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631760/
https://www.ncbi.nlm.nih.gov/pubmed/36340105
http://dx.doi.org/10.1021/acsomega.2c04510
_version_ 1784823886693531648
author Bekaroğlu, Gökçe Maide
İşçi, Sevim
author_facet Bekaroğlu, Gökçe Maide
İşçi, Sevim
author_sort Bekaroğlu, Gökçe Maide
collection PubMed
description [Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceutical and cosmetic products due to their many favorable properties, such as cation exchange capacity, adsorption capability, high specific surface area, and biocompatibility. Recently, several types of clay minerals have been widely studied for drug delivery applications due to their unique properties. The purification of montmorillonite is considered as a potentially useful step which may decrease the toxicity of impurities but which may increase the adsorption capacity of the montmorillonite. However, the effects on the toxicity and drug-release properties of purified montmorillonite have never been compared to that of raw montmorillonite. Montmorillonite was purified through decomposition of carbonates, dissolution of hydroxides, oxidation of organic materials, dialysis, and sedimentation. The raw and the purified montmorillonite were characterized using XRD, FTIR, and cation exchange capacities. Then, the cytotoxicity of raw and purified montmorillonite on normal hFOB cells was investigated to assess their biocompatibility in vitro. Finally, the efficacy of montmorillonite as a drug-delivering agent was investigated in vitro using cytotoxicity assays with the MCF7 cell line. The antitumor drug doxorubicin was loaded onto particles through electrostatic forces at 97.99% for CaMt and 96.79% for PMt. The drug-loading efficiency and release behavior of both clay minerals were determined. Results showed that both raw and purified montmorillonite did not significantly reduce the viability of normal cells at low concentrations (<500 μg/mL). At high concentrations, both raw and purified montmorillonite showed significant toxicity and the effect of impurities on toxicity were also more pronounced. Although drug loading was successful for both clay minerals there were differences in their controlled drug-release behavior. Doxorubicin-loaded raw and purified clay minerals significantly reduced MCF7 cell viability similar to pure DOX.
format Online
Article
Text
id pubmed-9631760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-96317602022-11-04 Raw and Purified Clay Minerals for Drug Delivery Applications Bekaroğlu, Gökçe Maide İşçi, Sevim ACS Omega [Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceutical and cosmetic products due to their many favorable properties, such as cation exchange capacity, adsorption capability, high specific surface area, and biocompatibility. Recently, several types of clay minerals have been widely studied for drug delivery applications due to their unique properties. The purification of montmorillonite is considered as a potentially useful step which may decrease the toxicity of impurities but which may increase the adsorption capacity of the montmorillonite. However, the effects on the toxicity and drug-release properties of purified montmorillonite have never been compared to that of raw montmorillonite. Montmorillonite was purified through decomposition of carbonates, dissolution of hydroxides, oxidation of organic materials, dialysis, and sedimentation. The raw and the purified montmorillonite were characterized using XRD, FTIR, and cation exchange capacities. Then, the cytotoxicity of raw and purified montmorillonite on normal hFOB cells was investigated to assess their biocompatibility in vitro. Finally, the efficacy of montmorillonite as a drug-delivering agent was investigated in vitro using cytotoxicity assays with the MCF7 cell line. The antitumor drug doxorubicin was loaded onto particles through electrostatic forces at 97.99% for CaMt and 96.79% for PMt. The drug-loading efficiency and release behavior of both clay minerals were determined. Results showed that both raw and purified montmorillonite did not significantly reduce the viability of normal cells at low concentrations (<500 μg/mL). At high concentrations, both raw and purified montmorillonite showed significant toxicity and the effect of impurities on toxicity were also more pronounced. Although drug loading was successful for both clay minerals there were differences in their controlled drug-release behavior. Doxorubicin-loaded raw and purified clay minerals significantly reduced MCF7 cell viability similar to pure DOX. American Chemical Society 2022-10-18 /pmc/articles/PMC9631760/ /pubmed/36340105 http://dx.doi.org/10.1021/acsomega.2c04510 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Bekaroğlu, Gökçe Maide
İşçi, Sevim
Raw and Purified Clay Minerals for Drug Delivery Applications
title Raw and Purified Clay Minerals for Drug Delivery Applications
title_full Raw and Purified Clay Minerals for Drug Delivery Applications
title_fullStr Raw and Purified Clay Minerals for Drug Delivery Applications
title_full_unstemmed Raw and Purified Clay Minerals for Drug Delivery Applications
title_short Raw and Purified Clay Minerals for Drug Delivery Applications
title_sort raw and purified clay minerals for drug delivery applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631760/
https://www.ncbi.nlm.nih.gov/pubmed/36340105
http://dx.doi.org/10.1021/acsomega.2c04510
work_keys_str_mv AT bekaroglugokcemaide rawandpurifiedclaymineralsfordrugdeliveryapplications
AT iscisevim rawandpurifiedclaymineralsfordrugdeliveryapplications